UC San Diego engineers have developed the thinnest optical device in the world: a waveguide that is three layers of atoms thin. The work is a proof of concept for scaling down optical devices to sizes that are orders of magnitude smaller than today’s devices.
The multiple sclerosis drug teriflunomide, paired with targeted cancer therapy, markedly shrinks patient-derived glioblastomas grown in mice by reaching stem cells at the tumor’s root, according to a new UC San Diego School of Medicine study published in Science Translational Medicine.
In a Phase III clinical trial, the drug volanesorsen significantly reduced blood fat (triglyceride) levels in participants with a rare disease called familial chylomicronemia syndrome; finding could also help inform better prevention methods and treatments for many types of heart disease.
The heart transplant program at UC San Diego Health has demonstrated the best one-year survival rate for patients in the United States among health care providers with a volume of more than 50 heart transplants per year, according to the Scientific Registry of Transplant Recipients.
Foreign-born Ph.D. graduates with science and engineering degrees from American universities apply to and receive offers for technology startup jobs at the same rate as U.S. citizens, but are only half as likely to actually work at fledgling companies, finds a study from Cornell and UC San Diego.
UC San Diego engineers have developed a soft robotic lens whose movements are controlled by the eyes—blink twice and the lens zooms in and out; look left, right, up or down and the lens will follow. The lens is the first example of an interface between humans and soft machines.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
